These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7960407)

  • 1. Structural studies of two antiaggregant RGDW peptides by 1H and 13C NMR.
    Kieffer B; Mer G; Mann A; Lefèvre JF
    Int J Pept Protein Res; 1994 Jul; 44(1):70-9. PubMed ID: 7960407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologically active Arg-Gly-Asp oligopeptides assume a type II beta-turn in solution.
    Johnson WC; Pagano TG; Basson CT; Madri JA; Gooley P; Armitage IM
    Biochemistry; 1993 Jan; 32(1):268-73. PubMed ID: 8418846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mimicry of beta II'-turns of proteins in cyclic pentapeptides with one and without D-amino acids.
    Weisshoff H; Präsang C; Henklein P; Frömmel C; Zschunke A; Mügge C
    Eur J Biochem; 1999 Feb; 259(3):776-88. PubMed ID: 10092864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and structure--activity relationship studies of a novel and specific peptide motif, Pro-X-X-X-Asp-X, as a platelet fibrinogen receptor antagonist.
    Hayashi Y; Katada J; Sato Y; Igarashi K; Takiguchi Y; Harada T; Muramatsu M; Yasuda E; Uno I
    Bioorg Med Chem; 1998 Mar; 6(3):355-64. PubMed ID: 9568289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folding of immunogenic peptide fragments of proteins in water solution. I. Sequence requirements for the formation of a reverse turn.
    Dyson HJ; Rance M; Houghten RA; Lerner RA; Wright PE
    J Mol Biol; 1988 May; 201(1):161-200. PubMed ID: 2843644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A conformational study of Lys-Arg-Asp-Ser and analogs, a series of potent antithrombotic peptides. An approach based on simulated annealing and 1H NMR.
    Meddeb S; Demaret JP; Ballini JP; Fiat AM; Jollès P; Ptak M; Vigny P
    J Biomol Struct Dyn; 1994 Apr; 11(5):959-81. PubMed ID: 7946066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solution stability of linear vs. cyclic RGD peptides.
    Bogdanowich-Knipp SJ; Chakrabarti S; Williams TD; Dillman RK; Siahaan TJ
    J Pept Res; 1999 May; 53(5):530-41. PubMed ID: 10424348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational study of cyclo(1,5)-Ac-Pen-Arg-Gly-Asp-Cys-NH2 in water by NMR and molecular dynamics.
    Siahaan TJ; Chakrabarti S; Vander Velde D
    Biochem Biophys Res Commun; 1992 Sep; 187(2):1042-7. PubMed ID: 1530602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The structure-antiaggregative activity relationship in a series of Arg-Gly-Asp analogs].
    Mel'nik OV; Martinovich VP; Golubovich VP
    Bioorg Khim; 2006; 32(2):137-43. PubMed ID: 16637284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arg-Gly-Asp constrained within cyclic pentapeptides. Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1.
    Aumailley M; Gurrath M; Müller G; Calvete J; Timpl R; Kessler H
    FEBS Lett; 1991 Oct; 291(1):50-4. PubMed ID: 1718779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-resolution NMR studies of fibrinogen-like peptides in solution: structural basis for the bleeding disorder caused by a single mutation of Gly(12) to Val(12) in the A alpha chain of human fibrinogen Rouen.
    Ni F; Konishi Y; Bullock LD; Rivetna MN; Scheraga HA
    Biochemistry; 1989 Apr; 28(7):3106-19. PubMed ID: 2742828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional structure of the RGD-containing neurotoxin homologue dendroaspin.
    Sutcliffe MJ; Jaseja M; Hyde EI; Lu X; Williams JA
    Nat Struct Biol; 1994 Nov; 1(11):802-7. PubMed ID: 7634091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The aqueous conformation of cyclo(1,6)Ac-Cys-Arg-Gly-Asp-Phe-Pen-NH2.
    Siahaan TJ; Bruss D; Powell NA; Chakrabarti S; Conrad M
    Int J Pept Protein Res; 1994 Nov; 44(5):427-34. PubMed ID: 7896500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1H-NMR studies and secondary structure of the RGD-containing snake toxin, albolabrin.
    Jaseja M; Smith KJ; Lu X; Williams JA; Trayer H; Trayer IP; Hyde EI
    Eur J Biochem; 1993 Dec; 218(3):853-60. PubMed ID: 8281937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational studies of cyclo(L-Phe-L-Pro-Gly-L-Pro)2 by 1H- and 13C-nuclear magnetic resonance spectroscopy, and its enantioface-differentiating ability.
    Ishizu T; Fujii A; Noguchi S
    Chem Pharm Bull (Tokyo); 1993 Feb; 41(2):235-8. PubMed ID: 8500196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Backbone modifications in cyclic peptides. Conformational analysis of a cyclic pseudopentapeptide containing a thiomethylene ether amide bond replacement.
    Anwer MK; Sherman DB; Spatola AF
    Int J Pept Protein Res; 1990 Oct; 36(4):392-9. PubMed ID: 2079394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Internal mobility of cyclic RGD hexapeptides studied by 13C NMR relaxation and the model-free approach.
    Briand J; Kopple KD
    J Biomol NMR; 1995 Dec; 6(4):347-60. PubMed ID: 8563465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of conformation on the conversion of cyclo-(1,7)-Gly-Arg-Gly-Asp-Ser-Pro-Asp-Gly-OH to its cyclic imide degradation product.
    Bogdanowich-Knipp SJ; Jois SD; Siahaan TJ
    J Pept Res; 1999 Jul; 54(1):43-53. PubMed ID: 10448969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solution conformation of a model hexapeptide containing RGD sequence.
    Dhingra MM
    Indian J Biochem Biophys; 1992 Dec; 29(6):458-64. PubMed ID: 1294461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pseudo-beta I-turn. A new structural motif with a cis peptide bond in cyclic hexapeptides.
    Kessler H; Matter H; Gemmecker G; Diehl HJ; Isernia C; Mronga S
    Int J Pept Protein Res; 1994 Jan; 43(1):47-61. PubMed ID: 8138351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.